Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page
- Check3 days agoChange DetectedAdded results-related data to the Study Record Dates, including Results First Posted 2025-10-29. Updated associated dates to reflect new published outcomes.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision metadata updated to v3.5.0. The previous v3.4.3 entry was removed.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows a minor update to the study protocol/document version from v3.4.1 to v3.4.2, with no visible changes to study information.SummaryDifference0.1%

- Check61 days agoChange DetectedThe site revision updated from v3.4.0 to v3.4.1; no changes to study details, eligibility criteria, or results are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check76 days agoChange DetectedUI elements for showing/hiding a glossary were added, and several page metadata labels related to results posting and QC criteria were updated (including Revision: v3.4.0). Some legacy labels such as 'Estimated' for results timing and 'No FEAR Act data' entries were removed.SummaryDifference0.4%

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.